Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $1,715 - $1,899
11 Added 0.33%
3,382 $547,000
Q1 2023

May 02, 2023

SELL
$132.34 - $159.14 $397 - $477
-3 Reduced 0.09%
3,371 $536,000
Q4 2022

Jan 20, 2023

BUY
$102.55 - $135.33 $307 - $405
3 Added 0.09%
3,374 $0
Q3 2022

Nov 04, 2022

SELL
$95.28 - $116.93 $22,962 - $28,180
-241 Reduced 6.67%
3,371 $336,000
Q2 2022

Jul 27, 2022

BUY
$103.24 - $121.81 $1,342 - $1,583
13 Added 0.36%
3,612 $403,000
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $9,310 - $11,254
-100 Reduced 2.7%
3,599 $400,000
Q4 2021

Feb 17, 2022

SELL
$95.88 - $117.08 $14,382 - $17,562
-150 Reduced 3.9%
3,699 $414,000
Q3 2021

Oct 21, 2021

BUY
$84.42 - $106.62 $675 - $852
8 Added 0.21%
3,849 $370,000
Q2 2021

Jul 27, 2021

BUY
$67.66 - $84.76 $1,420 - $1,779
21 Added 0.55%
3,841 $322,000
Q1 2021

Apr 20, 2021

SELL
$67.06 - $75.82 $246,579 - $278,790
-3,677 Reduced 49.05%
3,820 $258,000
Q4 2020

Jan 25, 2021

BUY
$63.89 - $73.8 $478,983 - $553,278
7,497 New
7,497 $524,000
Q3 2020

Oct 13, 2020

SELL
$63.69 - $70.22 $436,149 - $480,866
-6,848 Closed
0 $0
Q2 2020

Jul 29, 2020

BUY
$58.54 - $67.94 $90,210 - $104,695
1,541 Added 29.04%
6,848 $449,000
Q1 2020

May 12, 2020

BUY
$49.46 - $64.78 $48,371 - $63,354
978 Added 22.59%
5,307 $320,000
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $4,231 - $4,755
89 Added 2.1%
4,329 $224,000
Q2 2019

Jul 29, 2019

BUY
$46.79 - $52.47 $198,389 - $222,472
4,240 New
4,240 $216,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $252B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track V Wealth Advisors LLC Portfolio

Follow V Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of V Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on V Wealth Advisors LLC with notifications on news.